Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy in a patient with renal failure?
Correct Answer: Anti-factor Xa activity
Description: LMW heparin and fondaparinux have long half lives and consistent SC absorption; therefore do not require monitoring and once daily SC doses are sufficient. Patients with end stage renal failure and morbid obesity may require monitoring with anti-factor Xa assay.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now